Search Results - "Freese, A."

Refine Results
  1. 1

    Immune responses to AAV in a phase I study for Canavan disease by McPhee, S. W. J., Janson, C. G., Li, C., Samulski, R. J., Camp, A. S., Francis, J., Shera, D., Lioutermann, L., Feely, M., Freese, A., Leone, P.

    Published in The journal of gene medicine (01-05-2006)
    “…Background Canavan disease is a rare leukodystrophy with no current treatment. rAAV‐ASPA has been developed for gene delivery to the central nervous system…”
    Get full text
    Journal Article
  2. 2

    Strong interaction physics at the luminosity frontier with 22 GeV electrons at Jefferson Lab by Adhikari, D., Afanasev, A., Armstrong, D. S., Avakian, H., Bacchetta, A., Balantekin, A. B., Benmokhtar, F., Bertone, V., Binosi, D., Brash, E. J., Brindza, P. D., Brodsky, S. J., Cardman, L. S., Chen, J.-P., Christopher, A., Christy, E., Cisbani, E., Constantinou, M., Costantini, G., Dusa, S. Covrig, Day, D., De Fazio, F., De Vita, R., de Téramond, G. F., Diefenthaler, M., Djalali, C., Elouadrhiri, L., Evans, G., Fanelli, C., Fernández-Ramírez, C., Gan, L., Gao, F., Gasparian, A., Giacosa, F., Guo, F.-K., Hague, T. J., Hayward, T., Illari, I., Italiano, A., Jarvis, N. S., Jenkins, D. J., Ji, C.-R., Jones, M., Jones, R. T., Keppel, C., Khachatryan, V., Kohl, M., Kuhn, S. E., Liao, J., Mack, D. J., Mamo, K. A., Mariani, C., Markowitz, P., Marukyan, H., Mathieu, V., Maxwell, J., McCaughan, M., Mezrag, C., Miller, G. A., Mineeva, T., Chàvez, J. M. Morgado, Nguyen, D., Niccolai, S., Niculescu, G., Ortega, P. G., Pandey, P., Pasquini, B., Passemar, E., Patel, T., Paul, S. J., Peng, J.-C., Perry, R. J., Piasetzky, E., Pilloni, A., Polosa, A. D., Pospelov, M., Qin, S.-X., Reimer, P. E., Richard, J.-M., Ritman, J., Rivero-Acosta, A., Rogers, T. C., Santiesteban, S. N., Sato, N., Schnell, G., Shepherd, M. R., Shrestha, S., Sparveris, N., Strakovsky, I. I., Strikman, M., Suresh, M., Szczepaniak, A. P., Sznajder, P., Tong, X.-B., Vallarino, S., Wagner, J., Williams, R., Ye, Z., Zhao, Z. W., Zheng, X.

    “…Here, the purpose of this document is to outline the developing scientific case for pursuing an energy upgrade to 22 GeV of the Continuous Electron Beam…”
    Get full text
    Journal Article
  3. 3

    Reframing one's teaching: Discovering our teacher selves through reflection and inquiry by Freese, Anne R.

    Published in Teaching and teacher education (2006)
    “…Learning to teach is a highly complex and multidimensional process. This self-study, conducted collaboratively by a preservice teacher and a teacher educator,…”
    Get full text
    Journal Article
  4. 4

    Habitat use of the endangered butterfly Euphydryas maturna and forestry in Central Europe by Freese, A, Benes, J, Bolz, R, Cizek, O, Dolek, M, Geyer, A, Gros, P, Konvicka, M, Liegl, A, Stettmer, C

    Published in Animal conservation (01-11-2006)
    “…The knowledge of ecological requirements of declining butterflies of European woodlands remains limited, which hinders conservation management of their…”
    Get full text
    Journal Article
  5. 5

    Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI by Janson, C G, McPhee, S W J, Francis, J, Shera, D, Assadi, M, Freese, A, Hurh, P, Haselgrove, J, Wang, D J, Bilaniuk, L, Leone, P

    Published in Neuropediatrics (01-08-2006)
    “…Canavan disease is a childhood leukodystrophy caused by mutations in the gene for human aspartoacylase ( ASPA), which leads to an abnormal accumulation of the…”
    Get more information
    Journal Article
  6. 6

    Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease by Leone, P., Janson, C. G., Bilianuk, L., Wang, Z., Sorgi, F., Huang, L., Matalon, R., Kaul, R., Zeng, Z., Freese, A., McPhee, S. W., Mee, E., During, M. J.

    Published in Annals of neurology (01-07-2000)
    “…With the ultimate goal of developing safe and effective in vivo gene therapy for the treatment of Canavan disease and other neurological disorders, we…”
    Get full text
    Journal Article
  7. 7

    Implementation of Pressure Injury Prevention Strategies in Acute Care: Results From the 2018-2019 International Pressure Injury Prevalence Survey by Edsberg, Laura E., Cox, Jill, Koloms, Kimberly, VanGilder-Freese, Catherine A.

    “…The purpose of this study was to evaluate the implementation of pressure injury (PI) prevention strategies in adult acute care settings in the United States…”
    Get full text
    Journal Article
  8. 8

    Suicide in prisons: describing trends and staff knowledge and preparedness to address suicide by Freese, Rebekah A., Canada, Kelli E., Nichols, Pagena M., McNamara, Brianna

    Published in International journal of prisoner health (05-09-2023)
    “…Purpose Suicide prevention and intervention in prisons is a challenge. Prisons were not designed to be clinical facilities, yet with the growing numbers of…”
    Get full text
    Journal Article
  9. 9

    Evaluating Learning Outcomes and Assessing Social Work Skill Development: Comparing Online vs. In-Person Education by Canada, Kelli E., Freese, Rebekah A., Bailey, Rachel M., Fitch, Dale

    Published in Journal of technology in human services (02-01-2022)
    “…This article presents results from an evaluation of learning outcomes in a social work skills class between online and in-person students. Students were…”
    Get full text
    Journal Article
  10. 10

    Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination by Zavazava, Nicholas, Fändrich, Fred, Zhu, Xiaofeng, Freese, Anja, Behrens, Dirk, Yoo‐Ott, Kyoung‐Ae

    Published in Journal of leukocyte biology (01-06-2000)
    “…The efficacy of two synthetic major histocompatibility complex (MHC)‐derived DA (RT1.Aa) 25‐mer peptides (residues 56–80 and 96–120) to modulate alloreactivity…”
    Get full text
    Journal Article
  11. 11

    Restorative gene therapy approaches to Parkinson's disease by Freese, A

    Published in The Medical clinics of North America (01-03-1999)
    “…Perhaps one of the most exciting developments in brain research of the past decade is the advent of genetic intervention in human neurologic disease. Although…”
    Get more information
    Journal Article
  12. 12

    Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease by McPhee, S.W.J., Francis, J., Janson, C.G., Serikawa, T., Hyland, K., Ong, E.O., Raghavan, S.S., Freese, A., Leone, P.

    Published in Brain research. Molecular brain research. (27-04-2005)
    “…The tremor rat is a spontaneous epilepsy model with a seizure phenotype caused by a deletion in the aspartoacylase ( ASPA) gene. The absence of ASPA expression…”
    Get full text
    Journal Article
  13. 13

    Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors by Swartz, KJ, During, MJ, Freese, A, Beal, MF

    Published in The Journal of neuroscience (01-09-1990)
    “…Excitatory amino acid (EAA)-mediated synaptic transmission is the most prevalent excitatory system within the mammalian brain. Activation of EAA receptors has…”
    Get full text
    Journal Article
  14. 14

    Tetramethylpiperidine-substituted phenazines as novel anti-plasmodial agents by Makgatho, Marema E., Anderson, Ronald, O'Sullivan, John F., Egan, Timothy J., Freese, Janet A., Cornelius, Nicolene, van Rensburg, Constance E.J.

    Published in Drug development research (01-06-2000)
    “…Two novel derivatives of clofazimine [3‐(p‐chloroanilino)‐10‐(p‐chlorophenyl)‐2,10‐dihydro‐2‐isopropylimino)phenazine] and the tetramethylpiperidine…”
    Get full text
    Journal Article
  15. 15

    Precision studies of QCD in the low energy domain of the EIC by Elouadrhiri, L., Afanasev, A., Contalbrigo, M., Cosyn, W., Deshpande, A., Liuti, S., Oh, Y., Richards, D., Vossen, A., Abdolmaleki, H., Albataineh, A., Aidala, C.A., Alexandrou, C., Avagyan, H., Baker, M., Bernauer, J.C., Bissolotti, C., Briscoe, W., Cao, Xu, Carlson, C.E., Cichy, K., Cloet, I.C., Cocuzza, C., Cole, P.L., Constantinou, M., Dilks, C., Djalali, C., Dusa, S.C., El-Bennich, B., El Fassi, L., Frederico, T., Freese, A., Gamberg, L., Ghoshal, R.R., Girod, F.X., Goncalves, V.P., Gotra, Y., Guo, F.K., Guo, X., Hatta, Y., Hayward, T., Isupov, E.L., Jacak, B., Jacobs, W., Jentsch, A., Ji, C.R., Joosten, S., Kang, Z., Kim, A., Klein, S., Kriesten, B., Kumar, A., Kumericki, K., Kuchera, M., Li, Jin, Li, X., Lin, H.-W., Liu, K.F., Liu, Xiaohui, Mathieu, V., McEneaney, M., Mekki, A., Mkrtchyan, H., Mochalov, V., Morozov, V., Nadel-Turonski, P., Okorokov, V.A., Onyie, E., Pappalardo, L.L., Papandreou, Z., Polys, N., Prokudin, A., Przybycien, M., Qiu, J.-W., Ringer, F., Roy, B.J., Schäfer, A., Schmookler, B., Schweitzer, P., Seidl, R., Semenov-Tian-Shansky, K.M., Serna, F., Signori, A., Strakovsky, I., Sufian, R.S., Teodorescu, L., Terry, J., Tessarotto, F., Timmer, C., Cazares, L. Valenzuela, Vladimirov, A., Voutier, E., Watts, D., Wilson, D., Winney, D., Ye, Z., Ye, Zh, Yuan, F., Zachariou, N., Zahed, I.

    Published in Progress in particle and nuclear physics (01-07-2023)
    “…This White Paper aims at highlighting the important benefits in the science reach of the EIC. High luminosity operation is generally desirable, as it enables…”
    Get full text
    Journal Article
  16. 16

    Efficacy of Liposomal Bupivacaine Infiltration on the Management of Total Knee Arthroplasty by Sakamoto, Bryan, Keiser, Shelly, Meldrum, Russell, Harker, Gene, Freese, Andrew

    Published in JAMA surgery (01-01-2017)
    “…Liposomal bupivacaine is a novel extended-duration anesthetic that has recently been used for local infiltration in total knee arthroplasty (TKA). Athough…”
    Get more information
    Journal Article
  17. 17

    Infection of Cultured Central Nervous System Neurons with a Defective Herpes Simplex Virus 1 Vector Results in Stable Expression of Escherichia coli β-Galactosidase by Geller, Alfred I., Freese, Andrew

    “…We have developed a defective herpes simplex virus (HSV) vector system that permits the introduction of virtually any gene into mammalian central nervous…”
    Get full text
    Journal Article
  18. 18

    Long-term follow-up after gene therapy for canavan disease by Leone, Paola, Shera, David, McPhee, Scott W J, Francis, Jeremy S, Kolodny, Edwin H, Bilaniuk, Larissa T, Wang, Dah-Jyuu, Assadi, Mitra, Goldfarb, Olga, Goldman, H Warren, Freese, Andrew, Young, Deborah, During, Matthew J, Samulski, R Jude, Janson, Christopher G

    Published in Science translational medicine (19-12-2012)
    “…Canavan disease is a hereditary leukodystrophy caused by mutations in the aspartoacylase gene (ASPA), leading to loss of enzyme activity and increased…”
    Get more information
    Journal Article
  19. 19

    Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro by BERMAN, P. A, HUMAN, L, FREESE, J. A

    Published in The Journal of clinical investigation (01-12-1991)
    “…Malaria parasites, unable to synthesize purine de novo, use host-derived hypoxanthine preferentially as purine source. In a previous study (1990. J. Biol…”
    Get full text
    Journal Article
  20. 20

    Prospects for gene therapy in Parkinson's disease by Freese, A, Stern, M, Kaplitt, M G, O'Connor, W M, Abbey, M V, O'Connor, M J, During, M J

    Published in Movement disorders (01-09-1996)
    “…Numerous advances in in vivo and ex vivo gene-therapy approaches to Parkinson's disease offer promise for direct clinical trials in patients in the next…”
    Get more information
    Journal Article